COVID-19: Pharmidex Contingency Plan
March 19, 2020

Pharmidex are taking all the necessary steps to ensure the progression of client studies during these difficult time.

COVID-19: Pharmidex Contingency Plan


We are taking all necessary steps to ensure that studies proceed, while preserving the health and safety of staff. Summary of key steps taken at Pharmidex:


- Following the relevant guidelines issued by Public Health England.


- Limiting access to only essential people in our laboratories and cancelling/rescheduling all non-critical visitors. All visitors must confirm COVID-19 status prior to arrival.


- Cancelled all non-essential business travel.


- Closely communicating with suppliers regarding the status of their inventories and their business continuity plans and identifying alternate sources for supplies.


- Implemented strict sanitization practices to prevent cross contamination between staff, including providing our staff with resources and up-to-date information and guidance.


- To prevent the potential spread of the infection amongst employees, staff will declare any potential close contact with infected individuals and follow the relevant health guidelines.


- Our operations team will ensure adequate staffing cover so as not to compromise client studies.


We will keep you updated if the situation changes resulting in any impact on progression of your projects.


Best wishes to everyone during these tough times.

April 30, 2025
We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.
April 28, 2025
We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!
April 28, 2025
We’re excited that Ash Alavijeh , our Head of Operations, will attend the Biotech Matchmaking Event on 29 April 2025 at the Old Divinity School, St John’s College, Cambridge. 🔗 (Biotech Matchmaking Event - The Milner Therapeutics Institute) Ash looks forward to meeting attendees, discussing new collaborations, and driving forward the development of innovative drug candidates.  If you're attending, let’s connect and explore new opportunities together!
More Posts